[Je suis heureux de vous informer que nous venons de publier le rapport bi-annuel sur les médicaments essentiels "Essential Medicines 2006-2007 Biennial Report", des travaux de l'organisation mondiale de la santé (OMS) dans le domaine des médicaments essentiels et des politiques pharmaceutiques.
http://www.who.int/medicines/areas/access/biennial_report06_07/en/index.html
Le rapport, dont le lien a été inclus ci-dessus, fournit un
résumé des nombreuses activités en cours des deux dernières années, y compris le développement de normes de qualité pour les nouveaux médicaments essentiels et la préquilification des 65 médicaments prioritaires (...)Traduction JS modérateur]
---------------------------- Message original ----------------------------
"Hans Hogerzeil" <hogerzeilh@who.int>
--------------------------------------------------------------------------
E-DRUG: WHO Essential Medicines Bi-annual Report 2006-07
--------------------------------------------------------
Dear E-druggers,
I am pleased to inform you that we have just issued the Essential
Medicines 2006-2007 Biennial Report, on the work of the World Health
Organization (WHO) in the area of essential medicines and pharmaceutical
policies.
http://www.who.int/medicines/areas/access/biennial_report06_07/en/index.html
The report, for which the web-link has been included above, provides a
summary of the many ongoing activities of the past two years, including
developing global quality standards for new essential medicines and the
prequalification of 65 priority medicines; tailor-made technical support
in over 80 developing countries; and the marking of the 30-year
anniversary of the WHO Model List with the issue of the first WHO Model
List of Essential Medicines for Children.
The biennium also saw the launch of the International Medical Products
Anti-Counterfeiting Taskforce (IMPACT), extensive involvement in the
Inter-Governmental Working Group on Innovation, Public Health and
Intellectual Property (IGWG), and our active participation in UN
inter-agency medicine policy coordination and new global initiatives such
as UNITAID. The report will also be made available in French and Spanish.
More information and all documents issued by the programme are available
on our web-site: http://www.who.int/medicines
With best regards,
Dr Hans V. Hogerzeil
Director
Medicines Policy and Standards &
Acting Director
Technical Cooperation for Essential Drugs and Traditional Medicine World
Health Organization
CH-1211 Geneva 27
Switzerland
Tel: +41-22-791-3528
Fax: +41-22-791-4730
Email: hogerzeilh@who.int